Business
‘Treating obesity for the next 100 years’: Ozempic-maker Novo Nordisk targets tripling of Apac patient base
By sales volumes for its GLP-1 drugs, the company’s largest markets in the region are Australia, Japan, South Korea and India With…
Tag
obesity
News
WHO warning over shortage of obesity jabs
Michelle RobertsDigital health editor Fewer than one in 10 people who could benefit from obesity jabs like Wegovy are able to get them,…
News
Trump unveils deal with Eli Lilly and Novo Nordisk to lower costs and expand coverage for obesity drugs
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their…
News
Trump administration nearing deal to lower prices of obesity drugs
The Trump administration is expected to announce this week a deal with drugmakers Eli Lilly and Novo Nordisk to lower the prices of their…
Business
Pfizer boosts profit view as it battles for obesity startup
Pfizer raised its 2025 profit forecast for the second time this year, as ongoing cost cuts helped make up for slow sales growth that’s…
Business
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Pfizer on Friday (Oct 31) filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations in…
Business
Eli Lilly’s obesity and diabetes treatments fuel growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war…
Business
A new contender just rattled the obesity drug market
An experimental GLP-1 pill from Eli Lilly just outperformed Novo Nordisk’s oral semaglutide. In a new study, Eli Lilly’s oral pill,…
Business
Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicines
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs…
News
Obesity in India: How 'pot belly' went from status symbol to silent killer
The Indian pot belly - once a badge of prosperity, indulgence and aging respectability - has long been a target of satire and social…
Business
Merck snags Chinese obesity drug in nearly US$2 billion deal
MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 billion. Under the terms…
News
Should Medicare, Medicaid cover anti-obesity drugs? Doctors speak out
In what may be one of his final major acts in the White House, President Joe Biden has proposed extending Medicare and Medicaid to cover…
Business
Novo Nordisk launches obesity drug Wegovy in China
The price for a month’s supply of the starter dose of Wegovy will be 1,400 yuan Novo Nordisk said on Monday (Nov 18) it has launched its…
Business
Obesity drugmaker Novo Nordisk posts strong profit
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday…